Posted by admin on Aug 8th, 2022
State Board of Administration of Florida Retirement System lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 1.4% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 300,999 shares of the medical instruments supplier’s stock after selling 4,263 shares during the period. State Board of Administration of Florida Retirement System owned approximately 0.14% of DENTSPLY SIRONA worth $14,815,000 as of its most recent filing with the SEC.
A number of other large investors have also made changes to their positions in XRAY. Mutual of America Capital Management LLC increased its stake in DENTSPLY SIRONA by 0.7% in the fourth quarter. Mutual of America Capital Management LLC now owns 28,920 shares of the medical instruments supplier’s stock valued at $1,613,000 after acquiring an additional 201 shares during the period. Northwest Investment Counselors LLC increased its stake in DENTSPLY SIRONA by 1.4% in the first quarter. Northwest Investment Counselors LLC now owns 15,756 shares of the medical instruments supplier’s stock valued at $776,000 after acquiring an additional 217 shares during the period. Fifth Third Bancorp increased its stake in DENTSPLY SIRONA by 0.7% in the fourth quarter. Fifth Third Bancorp now owns 31,816 shares of the medical instruments supplier’s stock valued at $1,775,000 after acquiring an additional 222 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in DENTSPLY SIRONA by 3.1% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 7,387 shares of the medical instruments supplier’s stock valued at $412,000 after acquiring an additional 225 shares during the period. Finally, National Asset Management Inc. increased its stake in DENTSPLY SIRONA by 7.7% in the fourth quarter. National Asset Management Inc. now owns 4,116 shares of the medical instruments supplier’s stock valued at $230,000 after acquiring an additional 294 shares during the period. Institutional investors and hedge funds own 94.79% of the company’s stock.
A number of analysts recently weighed in on XRAY shares. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $53.00 to $51.00 in a research note on Wednesday, May 11th. William Blair cut shares of DENTSPLY SIRONA from a “market perform” rating to an “underperform” rating in a research note on Friday. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Sunday. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $48.00 to $44.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 20th. Finally, UBS Group raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and decreased their price objective for the stock from $58.00 to $47.00 in a research note on Wednesday, June 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $48.11.
Shares of XRAY stock opened at $36.84 on Monday. DENTSPLY SIRONA Inc. has a 1 year low of $33.78 and a 1 year high of $63.10. The firm’s 50 day moving average is $36.56 and its 200-day moving average is $43.83. The firm has a market capitalization of $7.94 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 2.96 and a beta of 0.91. The company has a current ratio of 1.45, a quick ratio of 1.03 and a debt-to-equity ratio of 0.38.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The company had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. During the same period in the prior year, the business earned $0.72 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up 841.1% on a year-over-year basis. Sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 2.41 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 8th. Investors of record on Friday, June 24th were issued a $0.125 dividend. The ex-dividend date was Thursday, June 23rd. This represents a $0.50 annualized dividend and a yield of 1.36%. DENTSPLY SIRONA’s dividend payout ratio is currently 29.59%.
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
State Board of Administration of Florida Retirement System Acquires 485 Shares of W. P. Carey Inc. (NYSE:WPC)
Russell Investments Group Ltd. Increases Stake in Fox Factory Holding Corp. (NASDAQ:FOXF)